Glenmark Pharmaceuticals

BSE : 532296 | NSE : GLENMARK

Industry : Pharmaceuticals | ISIN : INE935A01035 | FreeFloat : 55.00% | FnO : Yes | LotSize : 1150


Intellectual Capital (IC)7,021.95
Net Worth (NW)6,494.91
Intrinsic Worth (IW)13,516.86
Market Cap (MC)13,618.85
Economic Value Added-22.96
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)51.95%
IC Gross Margin (EBITDA/IC)31.83%
IC Net Margin (NPT/IC)11.08%
Knowledge Turnover (Sales/IC)1.61
Market to Intrinsic Value (MC/IW)1.01

As OfIntrinsic ValueMarket Price
30 Sep 2020Rs. 479.04Rs. 482.65
15 Jan 2021 - Rs. 512.10
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 517.23SellStrong Sell
KB > 50% : Yes50 DMA : Rs. 501.00
0 < M2IV < 1 : NoVol-Price trend : Falling

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Dec-17
C
2203.07
2180.50
299.53
224.15
153.67
104.74
114.90
Mar-18
C
2279.82
2349.37
263.26
255.91
248.47
151.63
100.58
Jun-18
C
2165.62
2303.83
485.10
390.62
311.61
222.78
-50.68
Sep-18
C
2581.33
2721.19
747.15
653.78
568.66
222.78
363.29
Dec-18
C
2555.05
2446.03
325.67
242.56
154.03
116.34
166.19
Mar-19
C
2563.47
2602.53
403.19
322.22
240.31
161.66
12.92
Jun-19
C
2322.88
2324.55
343.58
252.85
159.84
109.28
149.29
Sep-19
C
2815.04
2895.87
531.23
437.07
347.30
255.54
139.19
Dec-19
C
2735.56
2768.52
473.04
367.04
270.98
190.84
221.14
Mar-20
C
2767.49
2811.63
542.71
416.43
317.96
220.31
20.64
Jun-20
C
2344.79
2403.30
564.57
451.35
357.61
254.04
278.37
Sep-20
C
2952.48
2920.60
524.07
420.01
339.38
233.99
204.88
* C - Consolidated, S - Standalone